Our collaborations with healthcare professionals and organisations – from clinical research to sharing best practices to educational initiatives – benefit patients. With the help of such relationships, we are able to deliver innovative medicines based on a solid understanding of the ways disease impacts the lives of patients and how our medicines can and do fit into the treatment pathway.
The payments we make to support healthcare professionals, healthcare organisations and patient organisations follow the highest standards of ethical conduct and represent an investment in healthcare. Our disclosures regarding payments made to European healthcare professionals, healthcare organisations and patient organisations are consistent with the standards set forth in the Disclosure Code of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and national codes, and follow the call for greater transparency in respect of these vital relationships. Disclosures will help to strengthen the basis for collaboration in the future.
Click on the links below to review financial disclosures with respect to our support of patient organisations from 2013 to 2021.